This may reflect an intermediate position of DCIS between normal breast tissue and invasive breast cancer, the latter reportedly showing increased bFGF levels as compared to nonmalignant tissue (Smith et al, 1999). The gene discussed is FGF2; the disease is ductal breast carcinoma in situ.